How They Won It: Morgan Lewis Snags $577M Verdict For Asahi
By Erin Coe ( June 17, 2011, 8:10 PM EDT) -- When Switzerland-based Actelion Ltd. — accused of interfering with Asahi Kasei Pharma Corp.'s licensing agreement to develop cardiovascular drug Fasudil — began attacking the drug at trial by calling it ineffective and even dangerous, Asahi's attorneys from Morgan Lewis & Bockius LLP had a choice: they could either dodge the arguments or face them head on....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.